Cargando…

Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration

PURPOSE: To develop and validate an automatic retinal pigment epithelial and outer retinal atrophy (RORA) progression prediction model for nonexudative age-related macular degeneration (AMD) cases in optical coherence tomography (OCT) scans. METHODS: Longitudinal OCT data from 129 eyes/119 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Gigon, Anthony, Mosinska, Agata, Montesel, Andrea, Derradji, Yasmine, Apostolopoulos, Stefanos, Ciller, Carlos, De Zanet, Sandro, Mantel, Irmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590159/
https://www.ncbi.nlm.nih.gov/pubmed/34767623
http://dx.doi.org/10.1167/tvst.10.13.18
_version_ 1784598895122186240
author Gigon, Anthony
Mosinska, Agata
Montesel, Andrea
Derradji, Yasmine
Apostolopoulos, Stefanos
Ciller, Carlos
De Zanet, Sandro
Mantel, Irmela
author_facet Gigon, Anthony
Mosinska, Agata
Montesel, Andrea
Derradji, Yasmine
Apostolopoulos, Stefanos
Ciller, Carlos
De Zanet, Sandro
Mantel, Irmela
author_sort Gigon, Anthony
collection PubMed
description PURPOSE: To develop and validate an automatic retinal pigment epithelial and outer retinal atrophy (RORA) progression prediction model for nonexudative age-related macular degeneration (AMD) cases in optical coherence tomography (OCT) scans. METHODS: Longitudinal OCT data from 129 eyes/119 patients with RORA was collected and separated into training and testing groups. RORA was automatically segmented in all scans and additionally manually annotated in the test scans. OCT-based features such as layers thicknesses, mean reflectivity, and a drusen height map served as an input to the deep neural network. Based on the baseline OCT scan or the previous visit OCT, en face RORA predictions were calculated for future patient visits. The performance was quantified over time with the means of Dice scores and square root area errors. RESULTS: The average Dice score for segmentations at baseline was 0.85. When predicting progression from baseline OCTs, the Dice scores ranged from 0.73 to 0.80 for total RORA area and from 0.46 to 0.72 for RORA growth region. The square root area error ranged from 0.13 mm to 0.33 mm. By providing continuous time output, the model enabled creation of a patient-specific atrophy risk map. CONCLUSIONS: We developed a machine learning method for RORA progression prediction, which provides continuous-time output. It was used to compute atrophy risk maps, which indicate time-to-RORA-conversion, a novel and clinically relevant way of representing disease progression. TRANSLATIONAL RELEVANCE: Application of recent advances in artificial intelligence to predict patient-specific progression of atrophic AMD.
format Online
Article
Text
id pubmed-8590159
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-85901592021-11-24 Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration Gigon, Anthony Mosinska, Agata Montesel, Andrea Derradji, Yasmine Apostolopoulos, Stefanos Ciller, Carlos De Zanet, Sandro Mantel, Irmela Transl Vis Sci Technol Article PURPOSE: To develop and validate an automatic retinal pigment epithelial and outer retinal atrophy (RORA) progression prediction model for nonexudative age-related macular degeneration (AMD) cases in optical coherence tomography (OCT) scans. METHODS: Longitudinal OCT data from 129 eyes/119 patients with RORA was collected and separated into training and testing groups. RORA was automatically segmented in all scans and additionally manually annotated in the test scans. OCT-based features such as layers thicknesses, mean reflectivity, and a drusen height map served as an input to the deep neural network. Based on the baseline OCT scan or the previous visit OCT, en face RORA predictions were calculated for future patient visits. The performance was quantified over time with the means of Dice scores and square root area errors. RESULTS: The average Dice score for segmentations at baseline was 0.85. When predicting progression from baseline OCTs, the Dice scores ranged from 0.73 to 0.80 for total RORA area and from 0.46 to 0.72 for RORA growth region. The square root area error ranged from 0.13 mm to 0.33 mm. By providing continuous time output, the model enabled creation of a patient-specific atrophy risk map. CONCLUSIONS: We developed a machine learning method for RORA progression prediction, which provides continuous-time output. It was used to compute atrophy risk maps, which indicate time-to-RORA-conversion, a novel and clinically relevant way of representing disease progression. TRANSLATIONAL RELEVANCE: Application of recent advances in artificial intelligence to predict patient-specific progression of atrophic AMD. The Association for Research in Vision and Ophthalmology 2021-11-12 /pmc/articles/PMC8590159/ /pubmed/34767623 http://dx.doi.org/10.1167/tvst.10.13.18 Text en Copyright 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Gigon, Anthony
Mosinska, Agata
Montesel, Andrea
Derradji, Yasmine
Apostolopoulos, Stefanos
Ciller, Carlos
De Zanet, Sandro
Mantel, Irmela
Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration
title Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration
title_full Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration
title_fullStr Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration
title_full_unstemmed Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration
title_short Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration
title_sort personalized atrophy risk mapping in age-related macular degeneration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590159/
https://www.ncbi.nlm.nih.gov/pubmed/34767623
http://dx.doi.org/10.1167/tvst.10.13.18
work_keys_str_mv AT gigonanthony personalizedatrophyriskmappinginagerelatedmaculardegeneration
AT mosinskaagata personalizedatrophyriskmappinginagerelatedmaculardegeneration
AT monteselandrea personalizedatrophyriskmappinginagerelatedmaculardegeneration
AT derradjiyasmine personalizedatrophyriskmappinginagerelatedmaculardegeneration
AT apostolopoulosstefanos personalizedatrophyriskmappinginagerelatedmaculardegeneration
AT cillercarlos personalizedatrophyriskmappinginagerelatedmaculardegeneration
AT dezanetsandro personalizedatrophyriskmappinginagerelatedmaculardegeneration
AT mantelirmela personalizedatrophyriskmappinginagerelatedmaculardegeneration